ATE146477T1 - Antimitotische derivate von binären catharanthus roseus - Google Patents

Antimitotische derivate von binären catharanthus roseus

Info

Publication number
ATE146477T1
ATE146477T1 AT94922935T AT94922935T ATE146477T1 AT E146477 T1 ATE146477 T1 AT E146477T1 AT 94922935 T AT94922935 T AT 94922935T AT 94922935 T AT94922935 T AT 94922935T AT E146477 T1 ATE146477 T1 AT E146477T1
Authority
AT
Austria
Prior art keywords
pct
derivatives
antimitotic
binary
catharanthus roseus
Prior art date
Application number
AT94922935T
Other languages
English (en)
Inventor
Jean-Claude Jacquesy
Jacques Fahy
Christian Berrier
Dennis Bigg
Marie-Paule Jouannetaud
Fabien Zunino
Anna Kruczynski
Robert Kiss
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9449457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE146477(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE146477T1 publication Critical patent/ATE146477T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT94922935T 1993-07-21 1994-07-19 Antimitotische derivate von binären catharanthus roseus ATE146477T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308948A FR2707988B1 (fr) 1993-07-21 1993-07-21 Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.

Publications (1)

Publication Number Publication Date
ATE146477T1 true ATE146477T1 (de) 1997-01-15

Family

ID=9449457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94922935T ATE146477T1 (de) 1993-07-21 1994-07-19 Antimitotische derivate von binären catharanthus roseus

Country Status (15)

Country Link
US (1) US5620985A (de)
EP (1) EP0710240B1 (de)
JP (1) JP3606872B2 (de)
AT (1) ATE146477T1 (de)
AU (1) AU693460B2 (de)
BR (1) BR1100311A (de)
CA (1) CA2167694C (de)
DE (2) DE122010000012I1 (de)
DK (1) DK0710240T3 (de)
ES (1) ES2097659T3 (de)
FR (2) FR2707988B1 (de)
GR (1) GR3022659T3 (de)
LU (1) LU91660I2 (de)
NZ (2) NZ269172A (de)
WO (1) WO1995003312A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737208A1 (fr) * 1995-07-28 1997-01-31 Pf Medicament Nouvelles fluorovindolines, precurseurs d'analogues de la vinblastine et de la vinorelbine,leurs procedes de preparation et leur utilisation comme medicament
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
FR2783522A1 (fr) * 1998-09-21 2000-03-24 Pf Medicament Composes derives d'alcaloides de vinca, leur preparation et leur application en therapeutique
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
JP5448299B2 (ja) 2003-12-04 2014-03-19 アルバニー モレキュラー リサーチ， インコーポレイテッド ビンカ誘導体
EP1694330A4 (de) 2003-12-04 2009-06-24 Amr Technology Inc Vinorelbin-derivate
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
ATE507240T1 (de) * 2004-03-05 2011-05-15 Vegenics Pty Ltd Materialien und verfahren für wachstumsfaktorbindende konstrukte
FR2894966B1 (fr) * 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
JP5596924B2 (ja) * 2006-02-17 2014-09-24 カスケード プロドラッグ インコーポレイテッド ビンカアルカロイドｎ酸化物および類似体による過剰増殖疾患の処置
CN101108859A (zh) * 2006-07-17 2008-01-23 上海恒瑞医药有限公司 长春碱类化合物、其制备方法及其在医药上的用途
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
CN101235046B (zh) * 2007-01-29 2010-09-08 中国科学院上海药物研究所 长春碱衍生物、其制备方法和用途、以及包含该衍生物的药物组合物
FR2912406B1 (fr) 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
EP1997534A1 (de) * 2007-05-31 2008-12-03 Pierre Fabre Medicament Kombinationstherapie zur Krebsbehandlung mit Vinflunin und Trastuzumab
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
TW201026715A (en) 2008-12-23 2010-07-16 Pharmasset Inc Nucleoside phosphoramidates
JP6104504B2 (ja) 2008-12-23 2017-03-29 ギリアド ファーマセット エルエルシー ヌクレオシド類似体
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
ES2575160T3 (es) 2010-03-15 2016-06-24 The Board Of Trustees Of The University Of Illinois Inhibidores de las interacciones que unen la subunidad alfa de la beta integrina-proteína G
CL2011000716A1 (es) 2010-03-31 2012-04-20 Gilead Pharmasset Llc Formas cristalinas 1 6 de (s)-isopropil-2-(((s)-(((2r.3r.4r.5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-4-fluoro-3-hidroxi-4-metil tetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato; composicion y combinacion farmaceutica; y su uso para tratar una infeccion por el virus de la hepatitis c.
EP2655401B1 (de) 2010-12-20 2016-03-09 The Regents of the University of Michigan Hemmer der bindeinteraktion des epidermalen wachstumsfaktor-rezeptor-wärmeschock-proteins 90
CN103788117A (zh) * 2012-10-30 2014-05-14 何小解 一种脱水长春碱、长春瑞滨及长春氟宁连续化合成工艺
HU230462B1 (hu) 2013-05-30 2016-07-28 Richter Gedeon Nyrt. Új bisz-indol alkaloidok mint rákellenes gyógyszerek
EP3094622A1 (de) 2014-01-15 2016-11-23 Centre National de la Recherche Scientifique (C.N.R.S.) Wasserlösliche 4-azapodophyllotoxin-analoga
EP3250611B1 (de) 2015-01-26 2021-04-21 The University of Chicago Car-t-zellen zur erkennung krebsspezifischer il 13r-alpha2
JP7264592B2 (ja) 2015-01-26 2023-04-25 ザ ユニバーシティー オブ シカゴ ＩＬ１３Ｒα２結合剤及び癌治療におけるその使用
CA3014473A1 (en) * 2016-03-09 2017-09-14 Synbias Pharma Ag Vinorelbine monotartrate and its pharmaceutical use
EP3481422A1 (de) 2016-07-06 2019-05-15 Pierre Fabre Medicament Vinflunin und pd1- und/oder pdl1-inhibitor als pharmazeutische kombination
MA49849A (fr) 2017-08-07 2020-06-17 Amgen Inc Traitement du cancer du sein triple négatif ou du cancer colorectal comportant des métastases hépatiques par un anticorps anti-pd-l1 et un virus oncolytique
WO2020191344A1 (en) 2019-03-20 2020-09-24 The Regents Of The University Of California Claudin-6 bispecific antibodies
SG11202109986TA (en) 2019-03-20 2021-10-28 Univ California Claudin-6 antibodies and drug conjugates
JP2022530241A (ja) 2019-04-30 2022-06-28 インスチトゥート デ メディシーナ モリクラール ジョアン ロボ アントゥネス Ｃｄｋ阻害剤と組み合わせたｒａｎｋ経路阻害剤
WO2020242720A1 (en) 2019-05-02 2020-12-03 University Of Florida Research Foundation, Inc. Compositions for treatment of diffuse intrinsic pontine glioma
EP3986441A1 (de) 2019-06-24 2022-04-27 Amgen Inc. Inhibierung von sirp-gamma zur krebsbehandlung
FR3140369B1 (fr) 2022-10-04 2025-07-25 Univ Poitiers Procédé de fluoration et/ou cyclisation d’un alcène ou alcyne aminé en flux continu et installation pour la mise en œuvre du procédé

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2296418B1 (de) * 1974-12-30 1978-07-21 Anvar
US4110330A (en) * 1977-05-27 1978-08-29 Eli Lilly And Company 5'-Acetonylvincristine and related compounds
US4203898A (en) * 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4307100A (en) * 1978-08-24 1981-12-22 Agence Nationale De Valorisation De La Recherche (Anvar) Nor bis-indole compounds usable as medicaments
US4320058A (en) * 1980-12-29 1982-03-16 Eli Lilly And Company 20'-Hydroxyvinblastine and related compounds
HU193772B (en) * 1985-06-12 1987-11-30 Richter Gedeon Vegyeszet Process for producing new nitro-bis-indole derivatives

Also Published As

Publication number Publication date
WO1995003312A1 (fr) 1995-02-02
DE69401216T2 (de) 1997-07-03
FR10C0012I1 (de) 2010-04-16
JPH09500634A (ja) 1997-01-21
FR10C0012I2 (de) 2011-04-01
CA2167694C (fr) 2007-03-06
US5620985A (en) 1997-04-15
BR1100311A (pt) 1999-08-31
FR2707988B1 (fr) 1995-10-13
DE122010000012I1 (de) 2010-07-08
GR3022659T3 (en) 1997-05-31
CA2167694A1 (fr) 1995-02-02
JP3606872B2 (ja) 2005-01-05
AU7266694A (en) 1995-02-20
DK0710240T3 (da) 1997-06-02
NZ328612A (en) 2000-05-26
EP0710240B1 (de) 1996-12-18
EP0710240A1 (de) 1996-05-08
FR2707988A1 (fr) 1995-01-27
AU693460B2 (en) 1998-07-02
ES2097659T3 (es) 1997-04-01
NZ269172A (en) 1997-10-24
LU91660I2 (fr) 2010-05-10
DE69401216D1 (de) 1997-01-30

Similar Documents

Publication Publication Date Title
DE69401216D1 (de) Antimitotische derivate von binären catharanthus roseus
PL329922A1 (en) Quinoline carboxamides as inhibitors of the tumour necrosis factor and of phosphodiesterase
AU3115395A (en) Dihydrobenzofuranes
ATE547101T1 (de) Verfahren zur verwendung von diketopiperazinen und zusammensetzungen, die diese enthalten
FI914723A0 (fi) 17b-substituerade 4-aza-5a-androstan -3-jon-derivat och foerfarande foer framstaellning av desamma.
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
BG104899A (en) Antipicornaviral compounds and compositions, their pharmaceutical use and materials for their synthesis
AU2797695A (en) Thiazolidine derivatives, their preparation and drugs containing same
PL306402A1 (en) Thiazole derivatives, method of obtaining them and pharmaceutical preparations containing such derivatives
EA200000847A1 (ru) Противоопухолевые средства
DE69713273D1 (de) Verwendung von 3,4-Diphenylchromanen zur Herstellung eines Arzneimittels zur Behandlung bzw. Vorbeugung des Prostatakarzinoms
FI930831A0 (fi) Kelatkomplex och foerfarande foer deras framstaellning
BG101002A (bg) Заместени арилалкилтио-алкилтиопиридини и използване за борба с бактерии от рода helicobacter
EA199900534A1 (ru) Имидазопиридазины
DE59108770D1 (de) Fluorverbindungen als Aromatase-Inhibitoren
ATE149159T1 (de) Heteroarylmethylbenzole-aromatasehemmer
NO955278L (no) Substituerte aryltiolalkyltiopyridiner
RU94033096A (ru) Соединение, способ лечения и фармацевтическая композиция
DK1551850T3 (da) 2"-oxo-voruscharin og derivater deraf
DE59304826D1 (de) Substituierte 3-azabicyclo[3.2.0]heptan-derivate als zwischenprodukte
IT1245352B (it) Mezzi di contrasto per imaging cardiaco